PLYMOUTH MEETING, Pa. SDI announced July 29 that it had acquired healthcare information and services company Verispan.
SDI said it had created the healthcare industry’s most comprehensive longitudinal database serving the pharmacy, pharmaceutical, biotechnology, medical device, financial and consumer packaged goods market segments, among others. The company said the acquisition would combine its patient-level analytics with Verispan’s patient-level data and audit-based analytic solutions.
Clients will benefit, SDI stated, from such patient-level analytics capabilities and expertise as the tracking of pharmaceutical and device utilization, marketing effectiveness studies, market research audits, comprehensive managed care offerings, data integration services, clinical data collection programs, patient therapy management pharmacy programs and marketing services programs.
“The acquisition of Verispan is an important element of our growth strategy, and it extends our ability to meet client needs throughout the entire spectrum of health-care data and analyses, SDI chief executive officer Andrew Kress said. “We consider this an important milestone toward our goal of continuing to deploy innovative next-generation health-care analytic products and services.”